KPTI vs BIIB: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Biogen Inc in 2026
KPTI
Karyopharm Therapeutics Inc
$8.45
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | KPTI | BIIB | Winner |
|---|---|---|---|
| Market Cap | $186.66M | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.1% | -0.1% | KPTI |
| Gross Margin | 9.9% | 78.9% | BIIB |
Analyze KPTI
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or BIIB a better investment?
Comparing KPTI and BIIB: Karyopharm Therapeutics Inc has a market cap of $186.66M while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and BIIB?
KPTI (Karyopharm Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or BIIB?
KPTI has higher revenue growth at 0.1% vs -0.1% for BIIB.
Which company is more profitable: KPTI or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 9.9% for KPTI.
Which is the larger company: KPTI or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $186.66M for KPTI.
Should I buy KPTI or BIIB in 2026?
Both KPTI and BIIB have investment merit. KPTI trades at $8.45 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and BIIB stock?
Key differences: Market Cap ($186.66M vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (0.1% vs -0.1%), Gross Margin (9.9% vs 78.9%).